FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

LOTUSEYE

30.25
+3.1 (11.42%)
Updated 03:27 04/08 IST

LOTUSEYE Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for LOTUSEYE
Disclaimer
0% Bullish
0% Bearish

LOTUSEYE Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See LOTUSEYE Share Price Targets >>

LOTUSEYE Ratings

Long term LOTUSEYE rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live LOTUSEYE message board: Is LOTUSEYE buy or sell? Should I buy LOTUSEYE shares? Why are LOTUSEYE shares falling? Should I invest in LOTUSEYE stock?

  1. Home
  2. LOTUSEYE Forum

LOTUSEYE Share Price Discussion

Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • LOTUSEYE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization46.07
    Enterprise Value43.57
    Price to Earnings33.22
    Price to Book Value0.92
    Return on Capital Employed0.04
    Return on Equity0.03
    Face Value10
    Dividend Yield0.02
  • LOTUSEYE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 427.953127.630.05
    Aug 3292926.4527.15
    Jul 3128.528.526.1526.25
    Jul 3027.528.52727.65
    Jul 2927.2527.852727.05
  • LOTUSEYE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹29.99
    30 Day Moving Average₹30.72
    50 Day Moving Average₹29.05
    100 Day Moving Average₹26.71
    200 Day Moving Average₹24.96
  • LOTUSEYE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue38.0233.960.12
    Operating Profit4.343.290.32
    Profit Before Tax1.70.43.25
    Net Income1.750.433.07
  • LOTUSEYE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds50.1250.64-0.01
    Total Liabilities6.537.57-0.14
    Total Assets56.6558.21-0.03
  • LOTUSEYE - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity5.783.720.55
    Cash from Investing Activity-3.86-1.092.54
    Cash from Financing Activity-1.51-0.1211.58
    Net Cash Flow0.412.51-0.84
  • LOTUSEYE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.01
    Return on Equity0.030.01
    Return on Capital Employed0.040.01
  • LOTUSEYE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.27
    3 Year CAGR Growth in Operating Profit0.98
    3 Year CAGR Growth in EBIDTA0.09
    3 Year CAGR Growth in Net Income1.88
    3 Yr CAGR Growth - Diluted EPS1.88
  • LOTUSEYE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.31
    5 Year CAGR Growth in Operating Profit0.21
    5 Year CAGR Growth in EBIDTA1.05
    5 Year CAGR Growth in Net Income3.17
    3 Yr CAGR Growth - Diluted EPS3.2
  • LOTUSEYE - Recent News

    keyboard_arrow_down
  • LOTUSEYE - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020